IONS - Biogen updates Phase 1 data for Ionis-partnered Alzheimer's drug
2023-10-25 12:00:42 ET
More on Biogen, Ionis, etc.
- Biogen - Revised Revenue Forecasting To 2030 - New CEO Faces Major Challenges
- Biogen Inc. (BIIB) Management presents at Decentralized Clinical Trials in Focus Conference (Transcript)
- Biogen Inc. (BIIB) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)
- Praxis, Ionis stocks dip in wake of Praxis drug updates
- FDA approves Biogen’s biosimilar to Roche's arthritis drug Actemra
For further details see:
Biogen updates Phase 1 data for Ionis-partnered Alzheimer’s drug